Rokshaw can today announce an exclusive distribution partnership agreement has been reached with ECS Botanics, a leading pharmaceutical manufacturer of medical cannabis based in Australia, for their supply of their EU-GMP range of products.
This partnership grants exclusive distribution of three strains of dried EU-GMP medical cannabis flowers in the UK market, widening the collective range of products available for private prescription in the UK.
With their product range already known in the UK market, we are delighted to partner with ECS Botanics, a producer of the highest quality to align with our commitment towards providing the widest range of high quality medical cannabis treatment.
Richard Hodgson, Managing Director of Rokshaw: “We are delighted to announce our partnership with ECS Botanics, to continue providing their high quality EU-GMP product in the UK market and expand our total range available for private prescription.
“This partnership with a premium manufacturer of EU-GMP medical cannabis again shows our commitment towards widening access in the UK, with competitively priced products with a variety of strain profiles and dosage forms. Our best-in-class distribution service ensures that specialist prescribers can prescribe with confidence to ensure a sustainable treatment plan for their patients. ECS stood-out as a producer that we really wanted to work with so we are extremely excited that we have been able to make this happen and we look forward to seeing how our partnership develops.”
Nan-Maree Schoerie, Managing Director of ECS Botanics: “We are excited to begin our commercial relationship with Rokshaw, marking another substantial milestone with a new international customer and our second customer based in the United Kingdom.
“This new contract builds upon our existing international customer base, showcasing the export demand of our competitively priced EU-GMP certified, pharmaceutical-grade cannabis. The increasing traction among our clients reaffirms the quality and reliability of our products, positioning us as a trusted supplier in the global medicinal cannabis market. We are well positioned to meet the increasing demand and fulfill orders efficiently. This is attributed to the recent expansion of our cultivation areas and yield improvements from our R&D initiatives, both playing a key role in enabling us to significantly boost production.”
If you are a pharmacist or healthcare professional looking for more information, please visit our new medical cannabis page or contact us at medicalcannabis@rokshaw.co.uk
If you are an interested patient, please visit Curaleaf Pharmacy
About Rokshaw:
Rokshaw are the UK-leading experts in the manufacture and distribution of medical cannabis as part of Curaleaf International, the biggest cannabis company in the world. With our in-house state-of-the-art UK MHRA approved manufacturing facility, along with a comprehensive quality management system, we are meeting the growing patient demand for a consistent range of medical cannabis manufactured to EU-GMP standards, with varying dosage forms and levels of THC & CBD content.
As well as providing our own range of medical cannabis products, Rokshaw is proud to work with a number of high-quality partners who share the same vision of widening access to patients in the UK. Our capability to import bulk raw material and deliver a best-in-class manufacturing and distribution model for major medical cannabis brands is what sets us apart from the rest.
Our partner range, combined with our portfolio of UK-manufactured products represents the widest range on the market, giving specialist doctors a variety of treatment options for their patients.
About ECS Botanics:
ECS Botanics is an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. ECS utilises progressive and innovative cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licenced by the Australian Therapeutic Goods Administration to manufacture GMP (equivalent to PIC/S, EU agencies are all PIC/S members) certified products, ECS has become a leading provider of high quality, affordable medicinal cannabis.
